Magnetic nanoparticles: a novel platform for cancer theranostics.

Multifunctional nanoplatforms represent a cutting edge tool in biomedical applications as a result of their applicability in the concurrent monitoring of medical treatment. Magnetic nanoparticles (MNPs) have generated great interest in the field of cancer nanotheranostics owing to their intrinsic magnetic property that enables them to be used as contrast agents in magnetic resonance imaging and as a therapeutic system in conjunction with hyperthermia. In addition, the physical properties and biocompatibility of MNPs help them to act as efficient drug carriers for targeted therapeutic regimes. In this review, we have discussed the different theranostic applications of MNPs. Further, we have raised the current challenges associated with the clinical translation of MNPs along with future opportunities in this field.

[1]  Chandana Mohanty,et al.  Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. , 2010, Biomaterials.

[2]  Jinwoo Cheon,et al.  Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging , 2007, Nature Medicine.

[3]  Forrest M Kievit,et al.  PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo. , 2010, ACS nano.

[4]  C. Kumar,et al.  Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. , 2011, Advanced drug delivery reviews.

[5]  S. H. Koenig,et al.  Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles , 1995, Magnetic resonance in medicine.

[6]  S. Soenen,et al.  Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects. , 2010, Nanomedicine.

[7]  M. Dobrovolskaia,et al.  Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.

[8]  Victor C Yang,et al.  Cancer theranostics: the rise of targeted magnetic nanoparticles. , 2011, Trends in biotechnology.

[9]  S. Goodwin,et al.  Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  S. Kozireva,et al.  A novel approach for nucleic acid delivery into cancer cells. , 2012, Medicina.

[11]  W. Soboyejo,et al.  LHRH-functionalized superparamagnetic iron oxide nanoparticles for breast cancer targeting and contrast enhancement in MRI , 2009 .

[12]  Harald Sontheimer,et al.  Chlorotoxin Inhibits Glioma Cell Invasion via Matrix Metalloproteinase-2* , 2003, The Journal of Biological Chemistry.

[13]  Miqin Zhang,et al.  Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. , 2010, Advanced drug delivery reviews.

[14]  R. Weissleder,et al.  Targeted delivery of multifunctional magnetic nanoparticles. , 2007, Nanomedicine.

[15]  X. Qu,et al.  In situ monitoring Alzheimer's disease β-amyloid aggregation and screening of Aβ inhibitors using a perylene probe. , 2013, Small.

[16]  David Issadore,et al.  Magnetic Nanoparticles and microNMR for Diagnostic Applications , 2012, Theranostics.

[17]  C. Sunderland,et al.  Targeted nanoparticles for detecting and treating cancer , 2006 .

[18]  Ralph Weissleder,et al.  Magneto/optical annexin V, a multimodal protein. , 2004, Bioconjugate chemistry.

[19]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[20]  P. Wust,et al.  Temperature data and specific absorption rates in pelvic tumours: predictive factors and correlations. , 2001, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[21]  In Su Lee,et al.  Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. , 2009, Angewandte Chemie.

[22]  S. Sahoo,et al.  Nanotech approaches to drug delivery and imaging. , 2003, Drug discovery today.

[23]  J. Lewis,et al.  Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells , 2010, Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology.

[24]  Jerry S. H. Lee,et al.  Magnetic nanoparticles in MR imaging and drug delivery. , 2008, Advanced drug delivery reviews.

[25]  A. Akbarzadeh,et al.  Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine , 2012, Nanoscale Research Letters.

[26]  P. Wust,et al.  Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme , 2010, Journal of Neuro-Oncology.

[27]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  U. Sharma,et al.  Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy. , 2011, ACS applied materials & interfaces.

[29]  Erkki Ruoslahti,et al.  Remotely Triggered Release from Magnetic Nanoparticles , 2007 .

[30]  E. E. Carpenter,et al.  Chemically prepared magnetic nanoparticles , 2004 .

[31]  Donghoon Lee,et al.  Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles. , 2008, Nanomedicine.

[32]  U. Zimmermann,et al.  [Organ specific application of drugs by means of cellular capsule systems (author's transl)]. , 1976, Zeitschrift fur Naturforschung. Section C, Biosciences.

[33]  Ralph Weissleder,et al.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.

[34]  Conroy Sun,et al.  Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. , 2008, Small.

[35]  R. Weissleder,et al.  The transferrin receptor: a potential molecular imaging marker for human cancer. , 2003, Neoplasia.

[36]  Anna Moore,et al.  In vivo imaging of siRNA delivery and silencing in tumors , 2007, Nature Medicine.

[37]  S. Nie,et al.  Reexamining the Effects of Particle Size and Surface Chemistry on the Magnetic Properties of Iron Oxide Nanocrystals: New Insights into Spin Disorder and Proton Relaxivity , 2008 .

[38]  G. Pilwat,et al.  Organspezifische Applikation von pharmazeutisch aktiven Substanzen über zellulare Trägersysteme / Organ Specific Application of Drugs by Means of Cellular Capsule Systems , 1976 .

[39]  Ralph Weissleder,et al.  Nanoparticle imaging of integrins on tumor cells. , 2006, Neoplasia.

[40]  Hiroshi Maeda,et al.  Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. , 2010, Bioconjugate chemistry.

[41]  Peter Wust,et al.  Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme , 2006, Journal of Neuro-Oncology.

[42]  Keliang Liu,et al.  Size-controlled preparation of magnetite nanoparticles in the presence of graft copolymers , 2006 .

[43]  Vladimir P Torchilin,et al.  Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. , 2008, Biopolymers.

[44]  D. Huhn,et al.  Preclinical experiences with magnetic drug targeting: tolerance and efficacy. , 1996, Cancer research.

[45]  Donghoon Lee,et al.  Optical and MRI multifunctional nanoprobe for targeting gliomas. , 2005, Nano letters.

[46]  P. Doraiswamy,et al.  Metals in our minds: therapeutic implications for neurodegenerative disorders , 2004, The Lancet Neurology.

[47]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.

[48]  R. Ramanujan,et al.  Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy. , 2010, Acta biomaterialia.

[49]  Hakho Lee,et al.  Rapid detection and profiling of cancer cells in fine-needle aspirates , 2009, Proceedings of the National Academy of Sciences.

[50]  Hakho Lee,et al.  Micro-NMR for Rapid Molecular Analysis of Human Tumor Samples , 2011, Science Translational Medicine.

[51]  Yi-Xiang J. Wang.  Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. , 2011, Quantitative imaging in medicine and surgery.

[52]  K. Widder,et al.  Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents. , 1979, Advances in pharmacology and chemotherapy.

[53]  R. Semelka,et al.  Contrast agents for MR imaging of the liver. , 2001, Radiology.

[54]  Donghoon Lee,et al.  In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. , 2008, Small.

[55]  Philippe Robert,et al.  Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.

[56]  Robert Langer,et al.  A magnetically triggered composite membrane for on-demand drug delivery. , 2009, Nano letters.

[57]  Zhi-Feng Gan,et al.  A novel magnetic fluid based on starch-coated magnetite nanoparticles functionalized with homing peptide , 2009 .

[58]  Christian Bergemann,et al.  Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. , 2008, Biomaterials.

[59]  Ralph Weissleder,et al.  Magnetic relaxation switches capable of sensing molecular interactions , 2002, Nature Biotechnology.

[60]  J. Dobson,et al.  Magnetic nanoparticles for gene and drug delivery , 2008, International journal of nanomedicine.